ClinicalTrials.gg
Sign In

DrugBiological

Dalotuzumab clinical trials

Also written MK-0646.

studies test it
19
open now
0
in phase 3
0
first study started
2006

How studies write it

Studies that test it under each name

Name

Dalotuzumab
9

Development codes

MK-0646
16

Written with another drug

ridaforolimus + dalotuzumab
2
MK-8669, MK-0646
2

Studies by the year they started

19 studies that test it; most in 2008 (6)

Studies that test dalotuzumab, by start year
YearStudies
20062
20071
20086
20095
20103
20122

By phase

A phase 1/2 study counts in both.

Phase 1
11
Phase 2
11

What it is tested for

Each study’s main condition, where its own words name it.

Breast Neoplasms
5
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
2
Small Cell Lung Carcinoma
1
Adenocarcinoma
1
Multiple Myeloma
1
Neuroendocrine Tumors
1
Lung Neoplasms
1
Rectal Neoplasms
1

Who runs them

Industry 13 · Other 6

Merck Sharp & Dohme LLC (13) · M.D. Anderson Cancer Center (2) · NCIC Clinical Trials Group (1) · Memorial Sloan Kettering Cancer Center (1) · University of Kansas (1) · H. Lee Moffitt Cancer Center and Research Institute (1)

Often tested with

Tested in the same studies.

Ridaforolimus (3) · Erlotinib (2) · Cisplatin (1) · Etoposide (1) · Erlotinib Regimen (1) · Dasatinib (1)

Studies

Open first, then newest update. How each study uses dalotuzumab is read from its arms, and is right about nine times in ten.

Testing it · 19

Given in every arm · 3 — dalotuzumab is usual care beside what is tested

Codes

What other systems call dalotuzumab · ClinicalTrials.gg INT005973

  • MeSH (NLM) C569480dalotuzumabConfirmed NLM, Wikidata
  • UNII (FDA) 6YI1L648RHDALOTUZUMABConfirmed FDA, NLM, Wikidata
  • RxNorm 1432293Confirmed FDA, Wikidata
  • Wikidata Q5211586dalotuzumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C74011DalotuzumabConfirmed FDA, Wikidata
  • DrugBank DB11840One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.